Sign In
Buy BRKR
$62.70
+5.39 (+9.40%)
At Close: Jun 03, 2026
Bruker Announces Formation of New Bruker Spatial Biology Division
07:00am, Friday, 11'th Oct 2024
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensiv
BRKR Stock Might Gain From the Newly Launched OptoVolt Module
09:47am, Wednesday, 09'th Oct 2024
At the Neuroscience 2024 conference, Bruker released its latest OptoVolt module, which seamlessly integrates with Ultima 2Pplus microscope and NeuraLight 3D SLM.
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors
03:11pm, Monday, 07'th Oct 2024
BRKR acquires Dynamic Biosensors or DBS. DBS's unique products, along with BRKR's SPR portfolio, should help the latter establish a leading biosensors business.
Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
07:00am, Monday, 07'th Oct 2024
CHICAGO--(BUSINESS WIRE)---- $BRKR #BRKR--At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the OptoVolt™ module to further expand the advanced ne
Here's Why You Should Retain BRKR Stock in Your Portfolio Now
09:20am, Thursday, 03'rd Oct 2024
Bruker's robust growth potential across its Nano segment is encouraging. Yet, unfavorable currency movement is likely to pose a challenge.
Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
07:00am, Wednesday, 02'nd Oct 2024
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor dev
Is the Options Market Predicting a Spike in Bruker (BRKR) Stock?
12:46pm, Tuesday, 01'st Oct 2024
Investors need to pay close attention to Bruker (BRKR) stock based on the movements in the options market lately.
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Diagnostic Devices Market (2024 Edition): Analysis by Type (Imaging Devices, Microscopes, Immunoassays, Molecular Diagnostics, Others), Appl
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
10:00am, Wednesday, 18'th Sep 2024
Biognosys' Spectronaut®, the leading vendor-agnostic software for DIA proteomics, is now directly available from Thermo Fisher Scientific under a reselling agreement End users can get access to Therm
Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 05'th Sep 2024
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Should You Consider Retaining Bruker Stock in Your Portfolio Now?
01:36pm, Friday, 30'th Aug 2024
BRKR's robust growth potential across its major segments is encouraging. Yet, macro woes and competitive pressure can pose challenges.
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
08:27am, Thursday, 29'th Aug 2024
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels
Bruker Corporation to Present at Upcoming Investor Conferences
04:01pm, Friday, 23'rd Aug 2024
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the fol
Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
08:31am, Friday, 16'th Aug 2024
Bruker (BRKR) installs the 1.2 GHz Avance NMR Spectrometer at KBSI, enabling advanced scientific discoveries.
Bruker (BRKR) Reliance on International Sales: What Investors Need to Know
10:21am, Monday, 12'th Aug 2024
Evaluate Bruker's (BRKR) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
